An Open-Label Study of Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001)

Clinical trial NCT05025332 · COMPLETED

Trial details

NCT number: NCT05025332
Sponsor: Neuren Pharmaceuticals Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pitt Hopkins Syndrome

Start date: 2022-10-14
Primary completion: 2024-02-27
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.